APPLICATION OF EXPERIMENTAL DESIGN METHOD IN OPTIMIZATION OF COMPOSITION AND TECHNOLOGY FOR MATRIX TABLETS CONTAINING VACCINIUM MYRTILLUS LEAF DRY EXTRACT

Authors

  • O. A. Ruban National University of Pharmacy
  • T. Ye. Kolisnyk National University of Pharmacy
  • G. D. Slipchenko National University of Pharmacy

DOI:

https://doi.org/10.11603/2312-0967.2018.2.9003

Keywords:

Vaccinium myrtillus leaf dry extract, matrix tablets, wet granulation method, experimental design.

Abstract

The aim of the work. Studying the impact of the qualitative factors such as binder nature, moisture content and fractional composition, on the pharmaco-technological parameters of granulated tableting masses and matrix tablets containing Vaccinium myrtillus leaf dry extract.

Materials and Methods. The impact of the investigated factors was determined by tableting mass bulk and tapped densities, the Carr index and tablet crushing strength. All tests were performed according to the State Pharmacopoeia of Ukraine. Interpretation of the research data was carried out based on a dispersion analysis.

Results and Discussion. Using a three-factor dispersion analysis method it was found that binder nature significantly affects all the pharmaco-technological parameters studied, while moisture content is significant only for tablet crushing strength, and the fractional composition – only for bulk density of tableting mass.

Conclusions. On the basis of the studies conducted the following optimal parameters for the manufacturing of matrix tablets containing Vaccinium myrtillus leaf dry extract by wet granulation method were established: the use of 15 % solution of Plasdone S-630 copovidone as a granulating fluid; a residual moisture content of the tableting mass – (4.5±0.1) %; a fractional composition of the tableting mass – a mixture of equal amounts of granules less than 0.5 mm and granules larger than 0.5 mm but less than 1.0 mm in size.

Author Biographies

O. A. Ruban, National University of Pharmacy

Doctor of Pharmaceutical Sciences, Professor, Head of Industrial Technology of Drugs Department, National University of Pharmacy

T. Ye. Kolisnyk, National University of Pharmacy

postgraduate student of Industrial Technology of Drugs Department, National University of Pharmacy

G. D. Slipchenko, National University of Pharmacy

Candidate of Pharmaceutical Sciences, PhD (PharmSc), Associate Professor of Industrial Technology of Drugs Department, National University of Pharmacy

References

Hroshovy TA, Beley NM, Kucherenko LI, Vasenda MM, Markiv NV, Tryhubchak OV, et al. [Optimization of technological processes of drugs creation by means of mathematical planning of experiment]. Farmatsevt chasop. 2007;1:21-8. Ukrainian.

Hroshovyi TA, Martsenyuk VP, Kucherenko LI, Vronska LV, Huryeyeva CM. [Mathematical planning of experiment in pharmacy]. Ternopil: Ternopil State Medical University; 2008. Ukrainian.

Vasenda MM, Beley NM, Demchuk MB, Trigubchak OV, Chubka MB, Gureeva SM, et al. [The modern situation of the creation, manufacture and researches of tablet’s medicines. Report 1]. Farmatsevt chasop. 2009;4:77-80. Ukrainian.

Prescott JK, Barnum RA. On Powder Flowability. Pharm Technol. 2000;24(10):60-84.

Parikh DM (ed.). Handbook of Pharmaceutical Granulation Technology, 2nd edition. Boca Raton, FL, USA: Taylor & Francis Group, LLC; 2005.

Hartesi B, Sriwidodo, Abdassah M, Chaerunisaa AY. Starch as Pharmaceutical Excipient. Int. J. Pharm. Sci. Rev. Res. 2016;41(2):59-64.

Chowdhury MMH, Nawreen A, Rana MS. Formulation Development and In vitro Evaluation of Combination Product of Glyburide and Metformin Hydrochloride Tablet. Bangladesh Pharmaceutical J. 2013;16(2):195-203.

Kaerger JS, Edge S, Price R. Influence of particle size and shape on flowability and compactibility of binary mixtures of paracetamol and microcrystalline cellulose. Eur J Pharm Sci. 2004;22:173-9.

Koshovyi OM, Zagayko AL, Kolychev IO, Fylymonenko VP, Komisarenko AM, inventors; National University of Pharmacy, assignee. [Method for producing hypoglycemic composition from leaves of blueberry (Vaccinium myrtillus L.)]. UA patent 111134. March 25, 2016. Ukrainian.

State Pharmacopoeia of Ukraine, 2nd edition. Kharkiv: State Enterprise “Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines”; 2015.

Rekhi GS, Nellore RV, Hussain AS, Tillman LG, Malinowski HJ, Augsburger LL. Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets. J Control Release. 1999;59(3):327-42.

Adeleye OA, Femi-Oyewo MN, Odeniyi MA. Effect of compression pressure on mechanical and release properties of tramadol matrix tablets. Curr Issues Pharm Med Sci. 2015;28(2):120-5.

Elzayat EM, Abdel-Rahman AA, Ahmed SM, Alanazi FK, Habib WA, Sakr A. Studying the impact of formulation and processing parameters on the release characteristics from hydroxypropyl methylcellulose matrix tablets of diclofenac. Acta Pol Pharm. 2016;73(2):439-52.

Palmieri GF, Joiris E, Bonacucina G, Cespi M, Mercuri A. Differences between eccentric and rotary tablet machines in the evaluation of powder densification behaviour. Int J Pharm. 2005;298(1):164-75.

Tryhubchak OV, Ravliv YA, Hroshovyi TA. [Modern status of creation, production and research of tablet medicaments. Report 10]. Farmatsevt chasop. 2013;2:137-41. Ukrainian.

Published

2018-06-21

How to Cite

Ruban, O. A., Kolisnyk, T. Y., & Slipchenko, G. D. (2018). APPLICATION OF EXPERIMENTAL DESIGN METHOD IN OPTIMIZATION OF COMPOSITION AND TECHNOLOGY FOR MATRIX TABLETS CONTAINING VACCINIUM MYRTILLUS LEAF DRY EXTRACT. Pharmaceutical Review Farmacevtičnij časopis, (2), 41–47. https://doi.org/10.11603/2312-0967.2018.2.9003

Issue

Section

Pharmaceutical technology, biopharmacy, homeopathy, biotechnology